MedTrace Logo

A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine

NCT04689165 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1280

Last updated 2020-12-30

No results posted yet for this study

Summary

This study is a randomized, double-blinded, and controlled phase III clinical trial of the Group A meningococcal polysaccharide vaccine to evaluate the safety and immunogenicity of the vaccine in healthy infants aged 6-15 months.

Conditions

  • Meningitis, Meningococcal

Interventions

BIOLOGICAL

Experimental Group A meningococcal polysaccharide vaccine

Two doses of Experimental Group A meningococcal polysaccharide vaccine at the vaccination schedule of week 0, 12

BIOLOGICAL

Control Group A meningococcal polysaccharide vaccine

Two doses of Control Group A meningococcal polysaccharide vaccine at the vaccination schedule of week 0, 12

Sponsors & Collaborators

  • Yunnan Center for Disease Control and Prevention

    collaborator OTHER

  • Wei Cun

    lead UNKNOWN

Principal Investigators

  • Yan Zheng, Master · Yunnan Center for Disease Control and Prevention

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-14
Primary Completion
2021-05-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04689165 on ClinicalTrials.gov